US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS on April 14 for "Application of JAK inhibitor in kidney disease" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,604, issued on April 14, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China).

"Application of JAK inhibitor in kidney disease" was invented by Cheng Liao (Lianyungang, China), Lu Su (Lianyungang, China), Kan Lin (Lianyungang, China) and Jingyang Zhang (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an application of a JAK inhibitor in kidney disease. Specifically, provided is a use of a JAK inhibitor in the preparation of a drug for treating or preventing kidney disease."

The patent was filed on Dec. 10, 2021, under Application No. 18/266,345.

*For further information, including images, cha...